These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 20637431)
21. Do cytokeratin-positive-only sentinel lymph nodes warrant complete axillary lymph node dissection in patients with invasive breast cancer? Teng S; Dupont E; McCann C; Wang J; Bolano M; Durand K; Peltz E; Bass SS; Cantor A; Ku NN; Cox CE Am Surg; 2000 Jun; 66(6):574-8. PubMed ID: 10888134 [TBL] [Abstract][Full Text] [Related]
22. Determination of sentinel lymph node (SLN) status in primary breast cancer by prospective use of immunohistochemistry increases the rate of micrometastases and isolated tumour cells: analysis of 174 patients after SLN biopsy. Rydén L; Chebil G; Sjöström L; Pawlowski R; Jönsson PE Eur J Surg Oncol; 2007 Feb; 33(1):33-8. PubMed ID: 17174513 [TBL] [Abstract][Full Text] [Related]
23. Occult metastases in axillary lymph nodes as a predictor of survival in node-negative breast carcinoma with long-term follow-up. Reed W; Bøhler PJ; Sandstad B; Nesland JM Breast J; 2004; 10(3):174-80. PubMed ID: 15125740 [TBL] [Abstract][Full Text] [Related]
24. Concurrent invasive ductal carcinoma and chronic lymphocytic leukemia manifesting as a collision tumor in breast. Cheung KJ; Tam W; Chuang E; Osborne MP Breast J; 2007; 13(4):413-7. PubMed ID: 17593048 [TBL] [Abstract][Full Text] [Related]
25. Distinct hypermethylation profile of primary breast cancer is associated with sentinel lymph node metastasis. Shinozaki M; Hoon DS; Giuliano AE; Hansen NM; Wang HJ; Turner R; Taback B Clin Cancer Res; 2005 Mar; 11(6):2156-62. PubMed ID: 15788661 [TBL] [Abstract][Full Text] [Related]
26. Breast cancer pseudometastasis in a sentinel lymph node with cytokeratin-positive debris. Rao RS; Taylor J; Palmer J; Jennings WC Breast J; 2005; 11(2):134-7. PubMed ID: 15730460 [TBL] [Abstract][Full Text] [Related]
28. The role of sentinel node biopsy in ductal carcinoma in situ of the breast. Polom K; Murawa D; Wasiewicz J; Nowakowski W; Murawa P Eur J Surg Oncol; 2009 Jan; 35(1):43-7. PubMed ID: 18723312 [TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of residual breast disease and axillary node involvement for patients who had primary induction chemotherapy for advanced breast cancer. Escobar PF; Patrick RJ; Rybicki LA; Hicks D; Weng DE; Crowe JP Ann Surg Oncol; 2006 Jun; 13(6):783-7. PubMed ID: 16604475 [TBL] [Abstract][Full Text] [Related]
30. Predicting likelihood of having four or more positive nodes in patient with sentinel lymph node-positive breast cancer: a nomogram validation study. Unal B; Gur AS; Beriwal S; Tang G; Johnson R; Ahrendt G; Bonaventura M; Soran A Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1035-40. PubMed ID: 19327916 [TBL] [Abstract][Full Text] [Related]
31. Bilateral synchronous breast carcinomas followed by a metastasis to the gallbladder: a case report. Zagouri F; Sergentanis TN; Koulocheri D; Nonni A; Bousiotou A; Domeyer P; Michalopoulos NV; Dardamanis D; Konstadoulakis MM; Zografos GC World J Surg Oncol; 2007 Sep; 5():101. PubMed ID: 17848197 [TBL] [Abstract][Full Text] [Related]
32. Sentinel lymph node biopsy for breast cancer: the role of previous biopsy on patient eligibility. Miner TJ; Shriver CD; Jaques DP; Maniscalco-Theberge ME; Krag DN Am Surg; 1999 Jun; 65(6):493-8; discussion 498-9. PubMed ID: 10366201 [TBL] [Abstract][Full Text] [Related]
33. The predicted probability of having positive non-sentinel lymph nodes in patients who received neoadjuvant chemotherapy for large operable breast cancer. Evrensel T; Johnson R; Ahrendt G; Bonaventura M; Falk JS; Keenan D; Soran A Int J Clin Pract; 2008 Sep; 62(9):1379-82. PubMed ID: 17309608 [TBL] [Abstract][Full Text] [Related]
34. Endosalpingiosis in axillary lymph nodes simulating metastatic breast carcinoma: a potential diagnostic pitfall. Salehi AH; Omeroglu G; Kanber Y; Omeroglu A Int J Surg Pathol; 2013 Dec; 21(6):610-2. PubMed ID: 24021901 [TBL] [Abstract][Full Text] [Related]
35. Metachronous secondary primary occult breast cancer initially presenting with metastases to the contralateral axillary lymph nodes: report of a case. Kinoshita S; Hirano A; Kobayashi S; Komine K; Kyoda S; Takeyama H; Uchida K; Morikawa T; Nagase J; Sakamoto G Breast Cancer; 2010; 17(1):71-4. PubMed ID: 19259764 [TBL] [Abstract][Full Text] [Related]
36. Predictors of nonsentinel node metastasis in patients with breast cancer after sentinel node metastasis. Joseph KA; El-Tamer M; Komenaka I; Troxel A; Ditkoff BA; Schnabel F Arch Surg; 2004 Jun; 139(6):648-51. PubMed ID: 15197092 [TBL] [Abstract][Full Text] [Related]
37. Ductal carcinoma in situ-like structures in metastatic breast carcinoma. Kordek R Pathol Res Pract; 2005; 200(11-12):831-4. PubMed ID: 15792128 [TBL] [Abstract][Full Text] [Related]
38. Unusual association between cutaneous melanoma and axillary metastasis from occult breast cancer detected by sentinel node biopsy. Gallino G; Belli F; Greco M; Maffioli L; Ferro F; Brega Massone PP; Cascinelli N Eur J Surg Oncol; 2000 Aug; 26(5):515-6. PubMed ID: 11016475 [TBL] [Abstract][Full Text] [Related]
39. Axillary staging utilizing selective sentinel lymphadenectomy for patients with invasive breast carcinoma. Dale PS; Williams JT Am Surg; 1998 Jan; 64(1):28-31; discussion 32. PubMed ID: 9457034 [TBL] [Abstract][Full Text] [Related]
40. Invasive ductal carcinoma arising in ectopic breast tissue of the axilla. Case report and review of the literature. Sanguinetti A; Ragusa M; Calzolari F; D'Ajello F; Fioriti L; Papini D; Sidoni A; Roila F; Avenia N G Chir; 2010; 31(8-9):383-6. PubMed ID: 20843442 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]